openPR Logo
Press release

Global Hypertrophic Cardiomyopathy Therapeutics Market – Key Trends

02-02-2017 02:42 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Global Hypertrophic Cardiomyopathy Therapeutics Market –

The global hypertrophic cardiomyopathy (HCM) therapeutics market is dominated by companies exhibiting high sales. However, generic manufacturers are making their presence felt in the market gradually. As per Transparency Market Research (TMR), the top three companies in the market, Sanofi S.A., Pfizer, Inc., and Merck & Co., accounted for a share of over 64.5%, which points toward a highly consolidated vendor landscape.

Intense competition exists among the top companies in the market. These enterprises are mainly focusing on expanding and differentiating their product portfolio to enjoy sustainable growth.

Demand for HCM Therapeutics Surges due to Increasing Incidence of Congestive Heart Failure

“The prevalence of chronic cardiovascular ailments is fueling demand for effective treatment, which has been translating into lucrative sales opportunities for hypertrophic cardiomyopathy therapeutics,” said a lead TMR analyst. Heart diseases make one of the most common causes of death in both men and women around the world. According to TMR, the rising incidence of congestive heart failure considerably fuels demand for effective medications. This creates attractive opportunities for sales of hypertrophic cardiomyopathy therapeutics.

Read Full Report: http://www.transparencymarketresearch.com/hypertrophic-cardiomyopathy-therapeutics-market.html

"Besides this, successful interventions conducted across several countries to spread awareness about hypertrophic cardiomyopathy have also aided the expansion of the HCM therapeutics market,” said the TMR analyst. Furthermore, patients are now more aware about the latest medical advances, which augurs well for the market. ECG screening is the most efficient technology for diagnosing HCM. The success demonstrated by this technology has significantly contributed in fuelling demand for HCM therapeutics.

Rising Penetration of Advanced Medical Devices to Threaten Market Growth

Despite witnessing positive growth opportunities, the rising penetration of medical devices such as pacemakers and defibrillators in the healthcare sector has been inhibiting the HCM therapeutics market’s trajectory. Demand for gene therapy and implantable medical devices is rising as patients gain adequate knowledge about positive results offered by such advanced medical devices. The increasing acceptance of these medical devices could limit the scope of expansion for the HCM therapeutics market.

Nevertheless, drugs created specifically for the treatment of hypertrophic cardiomyopathy are yet to find approval. Once approved, this indication will bolster sales opportunities for the market players. Additionally, due to the high prevalence of unmet medical needs across Asia Pacific and the increasing medical expenditure in the region also boosts prospects for the HCM therapeutics market.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7553

Regionally, North America holds the largest share in the global HCM therapeutics market. However, as per TMR, the market is also expected to witness strong growth in Asia Pacific and Rest of the World. The Asia Pacific HCM therapeutics market is poised to expand at 2.9% CAGR between 2015 and 2023. By drug class, the market was led by calcium channel blockers in 2014. By drug class, the calcium channel blockers is expected to dominate the market. It held over 37.4% of the HCM therapeutics market in 2014.

TMR estimates the overall value of the global hypertrophic cardiomyopathy therapeutics market at US$1.2 bn in 2014. Exhibiting a moderate CAGR of 1.4% from 2015 to 2023, the market is expected to reach US$1.3 bn by the end of 2023.

This review is based on information published by TMR, in a report titled “Hypertrophic Cardiomyopathy Therapeutics (HCM) Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast, 2015 – 2023.”

Key Takeaways:

Demand for effective HCM therapeutics to grow as incidence of heart failure rises around the world
Calcium channel blockers emerged as dominant drug class in 2014 with a share of 37.4%
Asia Pacific to exhibit fastest CAGR of 2.9% between 2015 and 2023
The report segments the global HCM therapeutics market as:

Global Hypertrophic Cardiomyopathy Therapeutics, by Drug Class

Beta Adrenergic Blocking Agents
Calcium Channel Blockers
Antiarrhythmic Agents
Anticoagulants
Global Hypertrophic Cardiomyopathy Therapeutics, by Geography

North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
India
Japan
Rest of Asia Pacific
Rest of the World
Latin America
Middle East
Africa

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Hypertrophic Cardiomyopathy Therapeutics Market – Key Trends here

News-ID: 426994 • Views: 219

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for HCM

Recent Whitepaper: Digitization of Human Capital Management (HCM)
GENERAL OVERVIEW Human life and technology are closely linked- technology has been and still continues to make human life more comfortable. The world we live in is ever changing and constantly evolving. It’s a known fact that evolutions brings about a change in environment, technology and situations too. Fusion of technology in our day to day lives has made us more adaptable to our daily actions. As a result technology facilitates
HCM Software Market to Set Phenomenal Growth by 2025
A new market study on Global HCM Software Market with + data Tables, Pie Chart & Graphs is published to provide complete assessment of the Market highlighting evolving trends, current-to-future scenario analysis and growth factors validated with experts view. The study breaks market by revenue and volume (wherever applicable) and price history estimates for HCM Software. Some are the players from the coverage that are also part of the study
Global Human Capital Management (HCM) Market 2019: Ceridian HCM, Oracle, SAP, Ul …
Global Human Capital Management (HCM) Market 2019 report offers incisive information in a detailed manner related to key aspects of the market that are expected to have a computable impact on developmental prospects of the market over the forecast period. The major growth drivers, challenges, and trends prompting the market are examined thoroughly. An in-depth qualitative and quantitative data in relevance with the projected impact of these factors on the
HCM Software Market- Industry Analysis and Forecast (2019-2025)
Download Sample Research @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1738230 The Global HCM Software Industry Report 2019 is a professional and in-depth study on the current state of the HCM Software Market. Key #Companies Analysis- Oracle Corporation (U.S.), SAP SE (Germany), International Business Machines Corporation (U.S.), NetSuite Inc. (U.S.), Workday, Inc. (U.S.) , Ultimate Software Group, Inc. (U.S.) ADP, LLC (U.S.), Cornerstone OnDemand (U.S.), Benefitfocus Inc. (U.S.), BambooHR (U.S), PeopleFluent (U.S), Ultimate
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Opportunity Analysis, 2018 …
Hypertrophic Cardiomyopathy (HCM) is a genetic condition of heart muscle associated with the thickened heart muscle wall. HCM is caused due to the changes or mutation in one or more genes, which is inherited. Hypertrophic cardiomyopathy affects the muscular wall of heart making them stiff. This thickening makes harder for the heart to pump blood out of the heart and around the body. Shortness of breath, palpitations, chest pain, and
Apps Associates To Exhibit at Oracle HCM World, Boston
Apps Associates announces they are exhibiting at Oracle HCM World being held April 11-13 at the Marriott Copley Place in Boston. Stop by and visit us at Kiosk #4 and learn more about how our services and solutions can help you manage your human resources processes. Date: April 11-13, 2017 Times: 8:00 AM - 6:00 PM Venue: Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA 02116 Oracle HCM World is an event where human